| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
659,190 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2009-11-16 |
4 |
S |
$8.47 |
$16,940 |
D/D |
(2,000) |
21,489 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2009-08-06 |
4 |
S |
$8.79 |
$7,911 |
D/D |
(900) |
23,489 |
|
- |
|
| Tartaglia Anthony P |
Director |
– • – |
2009-06-03 |
4 |
A |
$8.81 |
$29,998 |
D/D |
3,405 |
37,966 |
|
- |
|
| Oconnor Kevin |
Director |
– • – |
2009-06-03 |
4 |
A |
$8.81 |
$14,995 |
D/D |
1,702 |
12,023 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2009-06-03 |
4 |
A |
$8.81 |
$29,998 |
D/D |
3,405 |
9,285 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2009-06-03 |
4 |
A |
$8.81 |
$14,995 |
D/D |
1,702 |
8,460 |
|
- |
|
| Anderson Paul S |
Director |
– • – |
2009-06-03 |
4 |
A |
$8.81 |
$14,995 |
D/D |
1,702 |
7,996 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2009-03-16 |
4 |
A |
$8.31 |
$29,085 |
D/D |
3,500 |
24,389 |
|
- |
|
| Frost Mark T |
Chief Financial Officer |
• – – |
2009-03-16 |
4 |
A |
$8.31 |
$33,240 |
D/D |
4,000 |
35,600 |
|
- |
|
| Jennings William Steven |
Senior Vice President |
• – – |
2009-03-16 |
4 |
A |
$8.31 |
$29,085 |
D/D |
3,500 |
13,500 |
|
- |
|
| D Ambra Constance M |
10% Owner |
– – • |
2009-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,500 |
4,613,928 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, CEO & President |
• • • |
2009-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,500 |
4,613,928 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2009-02-12 |
4 |
S |
$10.49 |
$20,980 |
D/D |
(2,000) |
20,889 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2008-11-20 |
4 |
S |
$8.96 |
$21,504 |
D/D |
(2,400) |
22,889 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2008-11-17 |
4 |
S |
$9.72 |
$26,351 |
D/D |
(2,711) |
25,289 |
|
- |
|
| D Ambra Constance M |
10% Owner |
– – • |
2008-11-05 |
4 |
S |
$13.04 |
$26,287 |
D/D |
(2,000) |
4,619,428 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, CEO & President |
• • • |
2008-11-05 |
4 |
S |
$13.04 |
$26,287 |
D/D |
(2,000) |
4,619,428 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & MfgOff |
• – – |
2008-11-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,000 |
|
- |
|
| Hagen Steven R |
VP Pharmaceutical Dev & Mfg |
• – – |
2008-11-03 |
4 |
A |
$13.20 |
$66,000 |
D/D |
5,000 |
28,000 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$13,950 |
D/D |
1,000 |
16,000 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$14,996 |
D/D |
1,075 |
5,880 |
|
- |
|
| Anderson Paul S |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$14,996 |
D/D |
1,075 |
6,294 |
|
- |
|
| Kuhla Donald E |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$14,996 |
D/D |
1,075 |
120,258 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$29,993 |
D/D |
2,150 |
6,758 |
|
- |
|
| Tartaglia Anthony P |
Director |
– • – |
2008-06-04 |
4 |
A |
$13.95 |
$29,993 |
D/D |
2,150 |
34,561 |
|
- |
|
620 Records found
|
|
Page 20 of 25 |
|
|
